TELA Bio director receives RSU and option grants
TELA Bio director Betty Jo Rocchio received new equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
TELA Bio director Betty Jo Rocchio received new equity awards. She was granted 11,675 restricted stock units of common stock, increasing her direct common stock holdings to 23,600 shares after the award. These units vest on the earlier of June 9, 2027, the next annual stockholder meeting, or a Change in Control, subject to her continued service.
She also received a stock option covering 17,335 shares of common stock at an exercise price of $0.935 per share, expiring on June 9, 2036. This option vests on the same schedule and service conditions as the restricted stock units.
Insider Trade Summary
Grant/Award: 29,010 shares
Grant/Award
2 txns
Insider
Rocchio Betty Jo
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,335 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 11,675 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 17,335 contracts (Direct);
Common Stock — 23,600 shares (Direct)
Footnotes (2)
- F1. These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
- F2. The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
RSU grant: 11,675 units
Common shares after grant: 23,600 shares
Option grant size: 17,335 shares
+3 more
6 metrics
RSU grant
11,675 units
Restricted stock units granted June 9, 2026
Common shares after grant
23,600 shares
Direct common stock held after RSU award
Option grant size
17,335 shares
Stock option covering common shares
Option exercise price
$0.935 per share
Strike price for stock option granted June 9, 2026
Option expiration
June 9, 2036
Expiration date of stock option grant
RSU vesting date
June 9, 2027
Latest possible vesting date, subject to earlier triggers
Key Terms
restricted stock units, Change in Control, Amended and Restated 2019 Equity Incentive Plan, stock option
4 terms
restricted stock units financial
"These restricted stock units vest on the earlier of (a) June 9, 2027..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Change in Control financial
"or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan)..."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Amended and Restated 2019 Equity Incentive Plan financial
"Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan)..."
stock option financial
"The option vests on the earlier of (a) June 9, 2027..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did TELA Bio (TELA) grant to director Betty Jo Rocchio?
TELA Bio granted director Betty Jo Rocchio 11,675 restricted stock units and a stock option for 17,335 shares at a $0.935 exercise price. Both awards are compensation-related grants, not open‑market purchases or sales, and were issued on June 9, 2026.
When do Betty Jo Rocchio’s new TELA Bio restricted stock units vest?
The 11,675 restricted stock units vest on the earlier of June 9, 2027, the next annual meeting of stockholders, or a Change in Control. Vesting in each case requires her continued service through the applicable vesting date under the company’s equity plan.
What are the key terms of Betty Jo Rocchio’s new TELA Bio stock option?
The new stock option covers 17,335 shares of TELA Bio common stock at a $0.935 exercise price and expires on June 9, 2036. It vests on the earlier of June 9, 2027, the next annual stockholder meeting, or a qualifying Change in Control, conditioned on continued service.
Are Betty Jo Rocchio’s TELA Bio Form 4 transactions open‑market buys or sells?
No, the Form 4 shows compensation grants, not market trades. Both the restricted stock units and stock option are coded as awards (transaction code A), reflecting equity compensation grants rather than open‑market purchases or sales of TELA Bio shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates